NSEPress Release4d ago · 31 Jul 2026, 11:41 am
Press Release
Fischer Medical Ventures Limited · FISCHER
✦ AI Summary▲ PositiveOrder Win
Fischer Medical Ventures Limited's wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has entered into a partnership with Parul Sevashram Hospital to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system.
Analysis Scores
Earnings Impact2/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact6/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership for installation of Inter-Op MRI Suite.".
Attachments (1)
📄pdf
Download →
FISCHER_31072026114109_Press_Release_31072026_SE.pdf
View document text
FISCHER MEDICAL VENTURES LIMITED
Registered Office Address: Survey No. 480/2 AP Medtech Zone
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: enquiry@fischermv.com | Website: www.fischermv.com | Contact 9080966548
July 31st, 2026
To To
BSE Limited National Stock Exchange of India Ltd.
Corporate Relationship Department Exchange Plaza, 5tll floor
25th Floor, P J Towers Plot No. C/ 1, G Block,
Dalal Street, Fort, Bandra-Kurla Complex Bandra (E),
Mumbai – 400 001 Mumbai - 400 051
BSE Scrip Code: 524743 NSE Symbol: FISCHER
Dear Sir/Madam,
Reg : Press Release on Time Medical International Ventures (India) Pvt Ltd, a
wholly owned subsidiary of Fischer Medical Ventures Limited, announces
partnership for installation of Inter-Op MRI Suite
We enclose a press release regarding Time Medical International Ventures (India) Pvt Ltd,
a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership
for installation of Inter-Op MRI Suite, for dissemination.
Thanking you,
Yours Truly,
For FISCHER MEDICAL VENTURES LIMITED
BALAJI GANDLA
COMPANY SECRETARY & COMPLIANCE OFFICER
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006
CIN L86900AP1993PLC118162
Corporate Office : Level 8, Prestige Palladium Bayan, No. 129-140 Greams
Road, Chennai, Tamil Nadu, 600006
Registered : No. 480/2 AP Medtech Zone, Nadupura Village,
Office Pedagantyadu Mandal, Visakhapatnam, 530032
Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary
of Fischer Medical Ventures Limited, announces partnership for installation of
Inter-Op MRI Suite.
Chennai, India – 31st July 2026 – Time Medical International Ventures (India) Private Limited
(“Time Medical India”), a wholly owned subsidiary of Fischer Medical Ventures Limited and a
global leader in advanced medical imaging solutions, has entered into a partnership with Parul
Sevashram Hospital, Vadodara, to install its revolutionary DRIS–iMRI Medharanya Suite, an
AI-enabled next-generation portable intraoperative MRI system.
Time Medical has developed a revolutionary new variant of MRI imaging technology — DRIS–
iMRI Medharanya, an AI-enabled, next-generation, portable and specialized MRI system
integrating Augmented Reality (AR), Artificial Intelligence (AI), Machine Learning
(ML), and Exoscope technologies. The intraoperative MRI platform is designed to
transform intraoperative imaging by providing surgeons with real-time visualization during
complex neurosurgical procedures, enabling unprecedented precision, safety, and surgical
control in procedures that traditionally rely on limited visual feedback.
Time Medical International Ventures has entered into a partnership to install its first Modern
Brain Suite: the DRIS–iMRI Medharanya system at Parul Sevashram Hospital,
Vadodara. Parul Sevashram Hospital’s vision of “Health for All” and its commitment to
accessible, high-quality healthcare closely aligns with TMIV’s focus on expanding access to
advanced imaging technologies and improving clinical outcomes through innovation-driven
diagnostics and interventional solutions.
Parul Sevashram Hospital serves as the teaching hospital of Parul Institute of Medical
Sciences & Research, a constituent institute of Parul University, Vadodara — one of
India's largest multidisciplinary private universities and the youngest in the country to
receive a NAAC A++ accreditation in its first assessment cycle. Spread across a 125-acre
eco-friendly campus, Parul University comprises 34 constituent institutes offering 250+
programmes across 21 faculties, including Medicine, Engineering, Pharmacy, Ayurveda,
Homoeopathy, Management, Law, and Design, to a student community of over 43,000,
including more than 2,500 international students from over 68 countries. Through this
upcoming partnership, the DRIS–iMRI Medharanya Suite is expected to strengthen the
university's academic and clinical ecosystem, giving medical students, residents, and faculty
at Parul University hands-on exposure to next-generation neurosurgical imaging technology.
Source: Parul University institutional profile, as published on the university's official website (paruluniversity.ac.in) and its member listing
with EURASHE (European Association of Institutions in Higher Education).
Medharanya Brain Suite OT is the next-generation integrated ecosystem encompassing
not only the intraoperative imaging through MRI -DRIS but also neurophysiology
navigation , exoscope solution , machine vision, VR-AR and robotronics in one intelligent
surgical ecosystem.
The DRIS–iMRI Medharanya platform integrates advanced imaging modalities
to seamlessly unify diagnostic and surgical workflows into a single, real-time
clinical ecosystem, enabling faster decision-making, unparalleled visualization of
complex neurological anatomy beyond conventional imaging, reduced surgical time with
enhanced patient safety through intraoperative guidance and verification, and integrated
pre-operative planning with intra-operative confirmation to support precision-driven
neurosurgical execution.
DRIS–iMRI Medharanya is being jointly developed by TMIV in collaboration with Dr. Iype
Cherian, a globally renowned neurosurgeon, educator, and innovator. TMIV worked
closely with surgeons to understand their real-world requirements in building the solution.
Dr. Cherian completed his M.Ch (Neurosurgery) at CMC Vellore and advanced fellowship
training in Skull Base and Vascular Neurosurgery at Nagoya, Japan. He is internationally
recognized for pioneering neurosurgical techniques, including novel craniotomy
approaches and the concept of Brain Cooling, influencing modern neurosurgical practice
and postoperative recovery strategies.
“Our upcoming partnership with Parul Sevashram Hospital to install the DRIS–iMRI
Medharanya will mark a landmark deployment of a next-generation intraoperative MRI
Brain Suite in India. This collaboration is expected to enhance neurosurgical precision,
improve clinical outcomes, and strengthen advanced neurocare capabilities at the
hospital.”- Ms. Svetlana Rao, Director, Time Medical India
About Time Medical International Ventures (India) Private Limited
Time Medical International Ventures (India) Private Limited is a global leader in
advanced medical imaging solutions and a wholly owned subsidiary of Fischer Medical
Ventures Limited.
Headquartered in Chennai, Time Medical India specializes in the design and manufacture
of high-performance, cost-effective MRI systems that democratize access to advanced
diagnostic imaging across emerging and developed markets alike.
For further information, please contact:
Fischer Medical Ventures Limited
Email: enquiry@fischermv.com
Website: www.fischermv.com
Contact: 9080966548
Disclaimer:
This investor release is not an offer to sell any securities or a solicitation to buy any securities of Fischer Medical Ventures Limited
(the "company") or its subsidiaries (together with the company, the "group"). Certain statements in this document may be forward
looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the
terms "believes", " estimates"," anticipates", " projects", " expects", " intends", " may", " will"," or " or, in each case, their negative
or other variations or comparable terminology, or by discussions of strategy, plans, aims, objectives, goals, future events or intention.
Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic
developments, technological risks, and many other factors that could cause our actual results to differ materially from those
contemplated by the relevant forward-looking statements.
Forward looking statements are not guarantees of future performance including those relating to general business plans and strategy
of the Company, its future outlook and growth prospects, and future
[Showing first 8,000 characters — download PDF for full document]